Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection.
Clin J Am Soc Nephrol., Jul;3(4):1168-74 (2008)
The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.
Transplantation., Dec;88(11):1303-11 (2009)
A decade of minimally invasive donation: experience with more than 1200 laparoscopic donor nephrectomies at a single institution.
Clin Transplant., 24(2):169-74 (2010)
Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction.
Transplantation., Jan;91(2):199-206 (2011)
T-cell-depleting agents in kidney transplantation: is there a place for alemtuzumab?
Am. J. Kidney Dis., Jan;59(1):15-8 (2012)
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
Sci Transl Med., Mar;4(124):124ra28 (2012)
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients.
Transplantation., Feb;81(3):463-8 (2006)
Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).
Clin J Am Soc Nephrol., May;1(3):539-45 (2006)
Late conversion of tacrolimus to sirolimus in a prednisone-free immunosuppression regimen in renal transplant patients.
Clin Transplant., 24(2):199-206 (2010)